Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 | Q4 FY252025-03-31 | Q3 FY252024-12-31 | Q2 FY252024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.59B | $1.50B | $1.46B | $1.39B | $1.48B | $1.37B | $1.33B |
| Cost of revenue | $808.50M | $891.20M | $840.70M | $814.40M | $763.10M | $839.30M | $760.20M | $750.10M |
| Gross profit | $684.20M | $697.20M | $655.50M | $645.90M | $628.00M | $641.20M | $610.40M | $578.80M |
| Gross margin | 45.8% | 43.9% | 43.8% | 44.2% | 45.1% | 43.3% | 44.5% | 43.6% |
| Research and development | $28.60M | $28.80M | $29.50M | $28.20M | $26.40M | $27.60M | $27.40M | $27.00M |
| Selling, general and administrative | $369.70M | $351.80M | $352.30M | $349.70M | $353.80M | $333.90M | $335.50M | $329.30M |
| Operating expenses | $398.00M | $380.30M | $382.20M | $380.10M | $382.00M | $425.00M | $365.10M | $359.10M |
| Operating income | $286.20M | $316.90M | $273.30M | $265.80M | $246.00M | $216.20M | $245.30M | $219.70M |
| Operating margin | 19.2% | 20.0% | 18.3% | 18.2% | 17.7% | 14.6% | 17.9% | 16.5% |
| EBITDA | $410.00M | $440.00M | $395.70M | $389.70M | $367.20M | $353.80M | $373.40M | $337.80M |
| Interest income | $0 | $0 | $0 | $2.40M | $0 | $0 | $0 | $1.10M |
| Interest expense | −$15.80M | −$15.10M | −$14.90M | −$14.90M | −$15.90M | −$17.20M | −$19.10M | −$19.70M |
| Income before taxes | $273.50M | $304.50M | $258.00M | $253.10M | $231.90M | $197.30M | $228.70M | $194.90M |
| Income taxes | $72.50M | $84.20M | $63.50M | $60.60M | $53.90M | $50.50M | $55.40M | $43.50M |
| Net income | $201.00M | $220.30M | $194.50M | $192.50M | $178.00M | $146.00M | $173.20M | $151.20M |
| Net margin | 13.5% | 13.9% | 13.0% | 13.2% | 12.8% | 9.9% | 12.6% | 11.4% |
| EPS, basic | $2.05 | $2.26 | $1.96 | $1.95 | $1.80 | $1.49 | $1.76 | $1.52 |
| EPS, diluted | $2.04 | $2.23 | $1.96 | $1.94 | $1.79 | $1.47 | $1.75 | $1.51 |
| Diluted shares | 97.90M | 98.60M | 98.60M | 98.80M | 98.80M | 98.90M | 98.90M | 99.20M |
Figures describe STERIS plc shares, not any token. As of Aug 7, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.